Trials / Sponsors / NanoBio Corporation
NanoBio Corporation
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | NB-001 Treatment of Recurrent Herpes Labialis Herpes Labialis | Phase 3 | 2012-10-01 |
| Completed | Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer Healthy Adult Volunteers | Phase 1 | 2011-05-01 |
| Completed | A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) Recurrent Herpes Labialis | Phase 3 | 2011-04-01 |
| Completed | A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis Recurrent Herpes Simplex Labialis | Phase 3 | 2011-04-01 |
| Completed | Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Healthy Adult Volunteers | Phase 1 | 2009-03-01 |
| Completed | Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis Herpes Labialis | Phase 2 | 2007-02-01 |
| Completed | Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail Onychomycosis | Phase 2 | 2007-01-01 |